DE1907000A1 - Verfahren zur Herstellung von in der serologischen Diagnostik verwendbaren Seren - Google Patents
Verfahren zur Herstellung von in der serologischen Diagnostik verwendbaren SerenInfo
- Publication number
- DE1907000A1 DE1907000A1 DE19691907000 DE1907000A DE1907000A1 DE 1907000 A1 DE1907000 A1 DE 1907000A1 DE 19691907000 DE19691907000 DE 19691907000 DE 1907000 A DE1907000 A DE 1907000A DE 1907000 A1 DE1907000 A1 DE 1907000A1
- Authority
- DE
- Germany
- Prior art keywords
- serum
- serological
- sera
- serums
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 16
- 230000000405 serological effect Effects 0.000 title claims description 12
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- 238000003745 diagnosis Methods 0.000 title 1
- 210000002966 serum Anatomy 0.000 claims description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 15
- 235000011187 glycerol Nutrition 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 3
- 108010088751 Albumins Proteins 0.000 claims description 3
- 230000036512 infertility Effects 0.000 claims description 3
- 102000007562 Serum Albumin Human genes 0.000 claims description 2
- 108010071390 Serum Albumin Proteins 0.000 claims description 2
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 229940072221 immunoglobulins Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000009589 serological test Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/96—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/76—Assays involving albumins other than in routine use for blocking surfaces or for anchoring haptens during immunisation
- G01N2333/765—Serum albumin, e.g. HSA
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Developmental Biology & Embryology (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL125191A PL62789B1 (https=) | 1968-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1907000A1 true DE1907000A1 (de) | 1969-11-06 |
Family
ID=19949875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19691907000 Pending DE1907000A1 (de) | 1968-02-12 | 1969-02-12 | Verfahren zur Herstellung von in der serologischen Diagnostik verwendbaren Seren |
Country Status (8)
| Country | Link |
|---|---|
| AT (1) | AT284340B (https=) |
| CH (1) | CH516935A (https=) |
| CS (1) | CS160095B2 (https=) |
| DE (1) | DE1907000A1 (https=) |
| DK (1) | DK121455B (https=) |
| FR (1) | FR2001727A1 (https=) |
| GB (1) | GB1250417A (https=) |
| RO (1) | RO54822A (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7110360B2 (ja) | 2017-10-09 | 2022-08-01 | テルモ ビーシーティー バイオテクノロジーズ，エルエルシー | 凍結乾燥方法 |
| CN113614477B (zh) | 2019-03-14 | 2023-04-28 | 泰尔茂比司特生物技术有限公司 | 冷冻干燥装载托盘组件及系统 |
-
1969
- 1969-02-07 AT AT127869A patent/AT284340B/de not_active IP Right Cessation
- 1969-02-07 CH CH193769A patent/CH516935A/de not_active IP Right Cessation
- 1969-02-10 FR FR6903068A patent/FR2001727A1/fr not_active Withdrawn
- 1969-02-11 DK DK72669A patent/DK121455B/da unknown
- 1969-02-12 RO RO5904969A patent/RO54822A/ro unknown
- 1969-02-12 GB GB1250417D patent/GB1250417A/en not_active Expired
- 1969-02-12 DE DE19691907000 patent/DE1907000A1/de active Pending
- 1969-02-12 CS CS94469A patent/CS160095B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK121455B (da) | 1971-10-18 |
| RO54822A (https=) | 1973-05-17 |
| CS160095B2 (https=) | 1975-02-28 |
| AT284340B (de) | 1970-09-10 |
| CH516935A (de) | 1971-12-31 |
| GB1250417A (https=) | 1971-10-20 |
| FR2001727A1 (https=) | 1969-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Scrimshaw | Embryonic development in poeciliid fishes | |
| DE2807202C2 (de) | Stabile Thymosinfraktion 5 und deren Herstellung | |
| Wolbach | The etiology of Rocky Mountain spotted fever:(A Preliminary report.) | |
| Ingebrigtsen | The influence of isoagglutinins on the final results of homoplastic transplantations of arteries | |
| DE1907000A1 (de) | Verfahren zur Herstellung von in der serologischen Diagnostik verwendbaren Seren | |
| Cotterill et al. | Egg White Lysozyme 1.: Relative Lysozyme Activity in Fresh Eggs Having Low and High Interior Quality | |
| Jones et al. | Growth and hatching of taeniid eggs | |
| DE2024341A1 (en) | Preservation of tissues and organs ingelatinous medium | |
| US2598881A (en) | Whole fresh egg semen diluter | |
| Brown et al. | Effect of some cryophylactic agents on turkey spermatozoa | |
| DE1806418A1 (de) | Eiweissartiges Reagens und Herstellungsverfahren hierfuer | |
| Williams et al. | Pulmonary mast cells in cattle and llamas at high altitude | |
| AT399056B (de) | Lyophilisiertes kontroll- oder referenzplasma bzw. kontroll- oder referenzserum für diagnostische zwecke | |
| LU503829B1 (de) | Ein Schutzmittel zum Einfrieren von menschlichem Sperma | |
| DE128419C (https=) | ||
| AT215080B (de) | Verfahren zur Herstellung haltbarer, getrockneter Präparationen lebender Zellen für Injektionszwecke | |
| Michaelis et al. | The Semiquinone of the Flavine Dyes, Including Vitamin B2 | |
| Johnson et al. | Studies on the single injection method of canine rabies vaccination | |
| Tsai et al. | Observation on the various factors influencing the increase of erythrocytic fragility induced by stasis | |
| CH619489A5 (https=) | ||
| DE391699C (de) | Verfahren zur Herstellung von spezifischen Fermentheilmitteln | |
| AT110561B (de) | Verfahren zur Herstellung von Scharlachserum. | |
| Juhn | Note on the hemolytic action of Sebright serum on Leghorn corpuscles | |
| DE1617734C (de) | Verfahren zur Herstellung eines immunologischen Reagens | |
| DE506095C (de) | Verfahren zum Haltbarmachen von Eigelb u. dgl. |